Su, L., Wang, Y., Wang, J., Mifune, Y., Morin, M. D., Jones, B. T., . . . Zhang, H. (2019). Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim. Journal of medicinal chemistry, 62(6), 2938. https://doi.org/10.1021/acs.jmedchem.8b01583
Chicago-Zitierstil (17. Ausg.)Su, Lijing, et al. "Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim." Journal of Medicinal Chemistry 62, no. 6 (2019): 2938. https://doi.org/10.1021/acs.jmedchem.8b01583.
MLA-Zitierstil (9. Ausg.)Su, Lijing, et al. "Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim." Journal of Medicinal Chemistry, vol. 62, no. 6, 2019, p. 2938, https://doi.org/10.1021/acs.jmedchem.8b01583.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.